Details of the Drug

General Information of Drug (ID: DMTQ35M)

• Drug Name: NasoShield

Indication

Disease Entry	ICD 11	Status	REF
Anthrax	1B97	Phase 1	[1]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: D2TH1E

References

• [1] ClinicalTrials.gov (NCT03352466) NasoShield Study of Safety and Immunogenicity (NasoShield). U.S. National Institutes of Health.